3 Companies Buying Back Cheap Stock Lately

→ America’s worst nightmare? (From Porter & Company) (Ad)

Photo with the words Stock Buybacks over image of skyline

Key Points

  • Stock buybacks are one of the most efficient ways to boost shareholder returns. They typically mean a stock is cheap and expected to rally in the short term. 
  • Three companies announced aggressive buyback programs for the year, representing a low to high single-digit net share repurchase. 
  • Potentially cheap, these three profit-churning companies could make for great watchlist additions.
  • 5 stocks we like better than The Goldman Sachs Group

Investors tend to focus on two things when measuring the performance of their investments, particularly in stocks. The lion's share is taken by appreciation, the classic 'buy low and sell high' behavior, with a second focus on bragging about quarterly – and sometimes monthly – dividend income. However, there is one forgotten and more effective way to measure shareholder returns. 

Stock buybacks are one of the most underrated ways to get rewarded as an investor. They allow the shareholder to own a larger piece of a company at no additional cost, not to mention their tax efficiency (more on that later). 

More than that, the underlying message that management sends the market when implementing buybacks is twofold. First, it could mean that a stock is considered cheap. And second, that management expects its stock to appreciate in the short term. Three companies fitting these two characteristics are Ulta Beauty Inc. NASDAQ: ULTA, Archer-Daniels-Midland Co. NYSE: ADM, and even Simon Property Group Inc. NYSE: SPG.

Stock Buybacks: It's Basically Free Money

Stock buybacks are typically funded in two ways. Ideally, companies will take away from free cash flow (operating cash flow minus capital expenditures) to buy back stock; others, however, choose to take on debt to buy back stock and artificially inflate their stock prices. 

Investors need to realize that the same applies to dividends. Companies should use free cash flow to pay shareholders, never debt. Now, here's why buybacks are much better than dividends. 

Sure, investors won't receive a 'paycheck' from the stock, but they are compounding their money more efficiently. Because free cash flow is considered income, it will be taxed. Dividends are also considered income, so they are also taxed. 


Buying back stock not only avoids double taxation but also increases investor ownership, as they now own a larger piece of the pie. Ideally, the pie (company) is growing, where the natural effect of compounding comes into play. 

Ulta's Profitability Makes for Irresistible Buybacks

Ulta Beauty Today

Ulta Beauty, Inc. stock logo
ULTAULTA 90-day performance
Ulta Beauty
$401.68
-2.28 (-0.56%)
(As of 05/14/2024 ET)
52-Week Range
$368.02
$574.76
P/E Ratio
15.42
Price Target
$539.55

According to the company's financials, Ulta stock generated an average return on invested capital (ROIC) rate of 25%. Because annual stock performance typically mirrors the long-term ROIC rate, Ulta stock makes for a potential wealth compounder, but is it at the right price?

Management thinks so, announcing a $2 billion buyback program, representing nearly 7.3% of the company's total shares. This company is considered part of the consumer staples sector, as consumers are likely to keep up with beauty and skincare products whether the economy is booming or busting. 

Because of this, analysts see a consensus price target of $556.50 a share, calling for a 37% upside from where the stock trades today. More than that, this $20 billion behemoth is set to grow its earnings per share (EPS) by 10% this year. Trading at 71% of its 52-week high, the stock could be justifiably cheap enough for insiders to buy back.

A Farmer's Year Makes Archer-Daniels a Pick

Archer-Daniels-Midland Today

Archer-Daniels-Midland Company stock logo
ADMADM 90-day performance
Archer-Daniels-Midland
$61.66
-0.97 (-1.55%)
(As of 05/14/2024 ET)
52-Week Range
$50.72
$87.30
Dividend Yield
3.24%
P/E Ratio
10.82
Price Target
$67.50

Retracing to 68% of its 52-week high, Archer-Daniels stock could be the top pick in the agricultural sector. Because global stocks-to-use ratios are at a cyclical low, farming stocks are setting up for a high production year, eventually needing to call on Archer-Daniels to store and transport harvested commodities.

A $2 billion buyback announcement, or roughly 6.4% of total shares, sends a message to investors that the stock could be cheap today. More than that, analysts at Bank of America Co. NYSE: BAC boosted their valuations to $74 for the stock, calling for a 23% upside from today's prices. 

The company's financials show a return on equity (ROE) rate of roughly 15% over the past five years. Because the company carries very little debt (28% of total capital) on its balance sheet, it provides investors with a smooth ride as the Federal Reserve (the Fed) decides on the direction of interest rates this year. 

A Resilient U.S. Consumer Gives Simon Room to Grow

After hitting a 3-year high, U.S. consumer sentiment readings keep the economy going. According to the ISM services PMI index trends, the consumer is solely responsible for carrying the market this year, as the manufacturing PMI had contracted for over a year. 

Another $2 billion buyback program means buying back up to 4.2% of total shares. This stock isn't as cheap as the others on this list on a price-action basis since it recently reached 90% of its 52-week high. However, compared to other real estate investment trusts (REITs), a 20.4x P/E ratio places Simon's stock at a 35% discount to the industry's 31.2x valuation. 

A 93% institutional ownership level in the stock means safety for Main Street investors. Speaking of institutions, The Goldman Sachs Group Inc. NYSE: GS boosted their price targets on the REIT up to $161 a share as of December 2023, calling for a 13% upside from where it trades today. 

Should you invest $1,000 in The Goldman Sachs Group right now?

Before you consider The Goldman Sachs Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and The Goldman Sachs Group wasn't on the list.

While The Goldman Sachs Group currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Beginners Guide To Retirement Stocks Cover

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Companies Mentioned in This Article

CompanyMarketRank™Current PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
Ulta Beauty (ULTA)
4.7728 of 5 stars
$401.68-0.6%N/A15.42Moderate Buy$539.55
Archer-Daniels-Midland (ADM)
3.8441 of 5 stars
$61.66-1.5%3.24%10.82Reduce$67.50
Simon Property Group (SPG)
3.5444 of 5 stars
$149.54+1.7%5.22%19.05Moderate Buy$140.22
Bank of America (BAC)
4.342 of 5 stars
$38.50+0.7%2.49%13.32Moderate Buy$38.70
The Goldman Sachs Group (GS)
4.5305 of 5 stars
$458.47+1.1%2.40%17.90Moderate Buy$440.57
Compare These Stocks  Add These Stocks to My Watchlist 

Gabriel Osorio-Mazilli

About Gabriel Osorio-Mazilli

  • gosoriomazzilli@gmail.com

Contributing Author

Value Stocks, Asian Markets, Macro Economics

Experience

Gabriel Osorio-Mazilli has been a contributing writer for MarketBeat since 2023.

Areas of Expertise

Value investing, long/short trading, options, emerging markets

Education

CFA Level I candidate; Goldman Sachs corporate training; independent courses

Past Experience

Analyst at Goldman Sachs, associate at Citigroup, senior financial analyst in real estate


Featured Articles and Offers

Biotech Boom: Stocks Skyrocketing & What's Next

Biotech Boom: Stocks Skyrocketing & What's Next

Dive into biotech's latest trends with Dylan Jovine: weight loss breakthroughs, smart chemo innovations, and expert stock evaluation tips.

Search Headlines: